Lee Sung 4
4 · Vir Biotechnology, Inc. · Filed Mar 28, 2024
Insider Transaction Report
Form 4
Lee Sung
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-03-27$9.89/sh−6,008$59,404→ 100,492 total
Footnotes (1)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.